Kate Chenlu Xie

Kate Xie practices at SoCal Eye Surgery Center in Long Beach, California.

Kate Xie's NPI, 1124415187, was assigned on April 16, 2015. Kate Xie graduated from UC Irvine School of Medicine in 2015. Kate Xie's Texas license number on file is S1305.

Kate Xie's primary practice is SoCal Eye Surgery Center, at 3300 East South St, Long Beach, CA 90805. The practice phone is (562) 531-2020.

Kate Xie's primary practice is SoCal Eye Surgery Center in Long Beach, California. Kate Xie is also affiliated with UCI Health - Orange. Dmand AI also links Kate Xie to 1 more medical group, named with a free account. Kate Xie's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Kate Xie practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Kate Xie's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Kate Xie is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Kate Xie's licenses on file in 2 states: Texas and California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation and glaucoma among the conditions Kate Xie treats.

CMS data shows 1,069 Medicare services from Kate Xie across 14 procedure codes in 2024, for 363 Medicare patients. Medicare paid $87,715 for them.

CMS counts 363 Medicare patients who saw Kate Xie in 2024. The largest group is 65 to 74, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Kate Xie's median patient age at 71, with 59% women.

In 2024, Kate Xie wrote 1,622 Medicare Part D claims for 493 patients. 55% of them were for generic drugs. CMS names the drug for 1,508 of them, across 19 drugs with 11 or more claims each, at $797,766 in total drug cost. In 2023, CMS named 1,657 claims across 21 drugs.

Kate Xie accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 113 procedures of cataract surgery by Kate Xie, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Kate Xie, published from 2015 to 2019. 2018 was the busiest year, with 2. The most frequent topics are Slit Lamp Microscopy. Kate Xie has published most often in Ocul Immunol Inflamm. Kate Xie's most frequent co-authors are Steven Lawrence Carter, MD, Robert Wade Crow, MD and Kevin Jwo, MD.

CMS Open Payments shows 106 general payments to Kate Xie from 27 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 61% of the total. Johnson & Johnson Surgical Vision, Inc. paid the most, $2,848.

Kate Xie graduated from UC Irvine School of Medicine in 2015.

Kate Xie is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.